Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantic Petroleum | ATLADKK | May 17, 2024 | 2.74 | -5.19 |
Audientes | AUDNTS | May 17, 2024 | 0.04 | -4.93 |
Bactiquant | BACTIQ | May 17, 2024 | 3.04 | +0.66 |
Bang & Olufsen | BO | May 17, 2024 | 10.16 | -1.36 |
BankNordik P/F | BNORDIKCSE | May 17, 2024 | 151.00 | 0.00 |
Bavarian Nordic | BAVA | May 17, 2024 | 178.75 | +3.12 |
Better Collective A/S | BETCODKK | May 17, 2024 | 194.40 | +5.65 |
BioPorto | BIOPOR | May 17, 2024 | 1.80 | -2.49 |
Boozt | BOOZTDKK | May 17, 2024 | 85.90 | -0.06 |
Brain+ | BRAINP | May 17, 2024 | 0.10 | -4.00 |
Brd. Klee B | KLEEB | May 17, 2024 | 4 340.00 | 0.00 |
Brdr. A & O Johansen Pref B | AOJB | May 17, 2024 | 74.30 | +1.09 |
Brøndbyernes IF Fodbold | BIF | May 17, 2024 | 0.70 | +3.88 |
Carlsberg A | CARLA | May 17, 2024 | 1 125.00 | -0.88 |
Carlsberg B | CARLB | May 17, 2024 | 989.80 | -0.24 |
cBrain | CBRAIN | May 17, 2024 | 310.00 | -0.48 |
Cemat | CEMAT | May 17, 2024 | 0.93 | +2.86 |
Cessatech A/S | CEASES | May 17, 2024 | 6.06 | 0.00 |
ChemoMetec | CHEMM | May 17, 2024 | 360.60 | -2.01 |
Coloplast B | COLOB | May 17, 2024 | 850.00 | +1.07 |
Columbus | COLUM | May 17, 2024 | 10.45 | 0.00 |
Conferize | CONFRZ | May 17, 2024 | 0.02 | +19.23 |
Copenhagen Capital | CPHCAPST | May 17, 2024 | 5.40 | 0.00 |
Copenhagen Capital 40 pct Pref 2032 | CPHCAPPREF32 | May 17, 2024 | 8.20 | +1.23 |
CS Medica | CSMED | May 17, 2024 | 3.85 | -7.89 |
D/S Norden | DNORD | May 17, 2024 | 332.60 | -0.83 |
DanCann Pharma A/S | DANCE | May 17, 2024 | 0.03 | 0.00 |
Danish Aerospace Company | DAC | May 17, 2024 | 3.10 | +1.97 |
Danske Andelskassers Bank | DAB | May 17, 2024 | 12.10 | 0.00 |
Danske Bank | DANSKE | May 17, 2024 | 201.10 | +2.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.